• Blog
  • Ureteral Stents Market Report

    Ureteral Stents Market Report

    Ureteral Stents Market Report
    Report code - SR2202 Delivery - 2 Weeks
    Get Free Sample |
    Ureteral stents Market Size, Share, Trend, Forecast, Competitive Analysis, and Growth Oppo See more...

    Market Insights

    The ureteral stents market was estimated at US$ 489 million in 2021 and is expected to grow at a CAGR of 7.11% during 2022-2028 to reach US$ ~ 740 million in 2028.

    A ureteral stent is a small, hollow tube that is inserted into the ureter to alleviate renal urine flow obstruction. These stents are used to treat a variety of diseases in people who have urine incontinence and kidney stones. These ureteral stents enable residual fragment flow without ureteral obstruction. A ureteral stent is actually a must for the majority of urological and kidney-related surgeries to allow for the appropriate healing of the ureter. Additionally, ureteral stents are necessary before, during, or after therapy due to the incidence of prostate cancer, tumours, or constriction or scarring of the ureter.

    The market is primarily being driven by the rising prevalence of urological and kidney-related illnesses as well as the use of technologically sophisticated stents for safe and efficient urological treatments. For instance, the American Cancer Society predicts that in 2020, over 191,930 men would receive a prostate cancer diagnosis. The rising incidence of these cases has therefore increased demand for ureteral stents, which is anticipated to fuel market expansion throughout the forecast period. The main reasons driving the market are the rising prevalence of urolithiasis (kidney and ureteral stones) and urine incontinence due to several factors such the rising amount of calcium in diet, alcohol consumption, and unhealthy lifestyles. For instance, according to a study published in the National Center for Biotechnology Information (NCBI), 12.0% of Indians are predicted to have urolithiasis in 2018, and 50.0% of those cases may result in renal function loss.

    Due to the rise in patients with kidney-related illnesses, nations like the U.S. and Canada have seen an increase in urological procedures in recent years. A third of American adults, or about 80.0 million individuals, are at risk for chronic renal disease, which is the tenth greatest cause of mortality in the country. More than 661,000 Americans experienced renal failure in 2017, according to data from the National Institute of Diabetes and Digestive and Kidney Disease (NIDDKD), of whom 200,000 were living with kidney transplants. As a result, there are now more kidney transplants being performed, which has raised demand for ureteral stents for post-operative comfort. Consequently, it is expected to increase the market growth.

    Several investments/guidelines in the industry have been directed in recent years, which would boost the overall market. Some of them are:

    • In the United States, kidney stones are thought to affect 1 in 11 people. The market is therefore driven by the requirement for ureteral stents during ureteroscopy and ureterorenoscopy, among other procedures used to treat kidney stones. Thus, the few elements causing such disorders or conditions are unhealthy lifestyle choices including alcohol use combined with an increase in smokers, an obese population, and dietary irregularities. The market for ureteral stents is anticipated to rise as a result.
    • Modern ureteral stent technology, such as the use of biodegradable materials with antimicrobial coatings, has enhanced and facilitated the treatment of kidney and urinary problems. Companies take an active role in developing products that lessen tissue irritation, stent migration, and ureterovesical reflux during procedures. For instance, Coloplast's Polyurethane and Silicone double loop ureteral stents, which are biocompatible and flexible polymer ureteral stents, are widely used by professionals for long-term implantation during urological surgery. During the projected period, this is anticipated to have a favourable effect on market growth.
    • A rising geriatric population is also projected to fuel market growth. For instance, according to the World Health Organization, there will be 2 billion elderly people worldwide by 2050.

    Segment Analysis

    Based on material, application, end user, and geography, the market has been divided into segments. Metallic and polymer are the market segments for ureteral stents that have been created based on material. Further sub-categories of polymer ureteral stents include silicone, polyurethane, and hybrid stents. The increasing use of these stents by doctors and patients is what is driving this market segment's rise. Due to a number of advantages over metallic stents, including greater flexibility and biocompatibility, polymers are now the material of choice for making stents. These factors make polymer stents the ideal material for long-term implantation since they lower the risk of infection and problems. Therefore, the aforementioned elements will continue to play a vital role in segment growth.

    Based on application, the ureteral stents market has been divided into kidney stones, kidney transplantation, tumors, urinary incontinence, and others. In 2021, the market was led by the kidney stones category. The adoption of a sedentary lifestyle and dietary practises that cause urolithiasis are two factors that are fueling the expansion of this market segment. For instance, a 2018 study published in the NCBI predicted that over 600,000 Americans get urinary stones each year. The requirement for ureteral stents during ureteroscopy and ureterorenoscopy, among other procedures used to treat kidney stones, is what is causing the segment to increase.

    The ureteral stents market is broken down geographically into areas like North America, Europe, Asia-Pacific, and the Rest of the World (RoW). North America dominated the market, and it is expected that this trend would continue in the near future. The market in North America is primarily being driven by sedentary lifestyle-related urological and kidney-related illnesses like kidney stones, chronic kidney disease, and urine incontinence. Additionally, the region's market is growing as a result of the existence of major industry players like Boston Scientific Corporation, Medline Industries, and Coloplast. In addition, raising government healthcare spending opens up new business prospects. For instance, the National Health Expenditure Accounts (NHEA) 2018 report shows that the United States spent 3.6 trillion USD on healthcare, up 4.6% over the previous year (USD 11,172 per person).

    Key Players

    There is stiff competition in the ureteral stents market. The market's leading players can concentrate on creating sophisticated urinary catheters that provide catheterization that reduces the danger of leakage and infection while preventing discomfort and resentment from urethral disorders. For example:

    • Brightwater Medical, Inc., a manufacturer of ureteral obstructions therapy devices, was acquired by Merit Medical Systems in June 2019. Through this acquisition, the business will integrate the biliary stent system from Bright Water into its line of goods and promote those goods internationally.
    • In June 2019, Boston Scientific Corporation acquired Vertiflex, Inc., a privately held business that created and marketed the Superion Indirect Decompression System, a minimally invasive device used to enhance physical function and lessen pain in people with lumbar spinal stenosis (LSS), a narrowing of the spinal canal that can result in compression of nearby nerves.

    The overall competitive landscape has been affected due to these mergers and acquisitions. The following are the major players in the ureteral stents market:

    • B. Braun Melsungen AG
    • BD
    • Boston Scientific Corporation
    • Coloplast Ltd.
    • Cook Medical
    • Medline Industries
    • Merit Medical Systems, Inc.
    • Olympus Corporation
    • Teleflex Incorporated

    Research Methodology

    This report offers high-quality insights and is the outcome of detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders and validation and triangulation with Stratview Research’s internal database and statistical tools. More than 1,000 authenticated secondary sources, such as company annual reports, fact book, press release, journals, investor presentation, white papers, patents, and articles have been leveraged to gather the data. We conducted more than 10 detailed primary interviews with the market players across the value chain in all four regions and with industry experts to obtain both the qualitative and quantitative insights.

    Report Features

    This report provides market intelligence in the most comprehensive way. The report structure has been kept such that it offers maximum business value. It provides critical insights into the market dynamics and will enable strategic decision making for the existing market players as well as those willing to enter the market. The following are the key features of the report:

    • Market structure: Overview, industry life cycle analysis, supply chain analysis
    • Market environment analysis: Growth drivers and constraints, Porter’s five forces analysis, SWOT analysis
    • Market trend and forecast analysis
    • Market segment trend and forecast
    • Competitive landscape and dynamics: Market share, product portfolio, product launches, etc.
    • Attractive market segments and associated growth opportunities
    • Emerging trends
    • Strategic growth opportunities for the existing and new players
    • Key success factors

    Frequently Asked Questions (FAQ)

    A ureteral stent is a small, hollow tube that is inserted into the ureter to alleviate renal urine flow obstruction. These stents are used to treat a variety of diseases in people who have urine incontinence and kidney stones. These ureteral stents enable residual fragment flow without ureteral obstruction. A ureteral stent is actually a must for the majority of urological and kidney-related surgeries to allow for the appropriate healing of the ureter.

    The market is expected to grow at a CAGR of 7.11% during 2022-2028.

    The market size is estimated to grow from USD 489 million in 2021 to USD ~ 740 million by 2028.

    North America is expected to remain the largest market for Ureteral stents during 2022-2028.

    B. Braun Melsungen AG, BD, Boston Scientific, Corporation, Coloplast Ltd., Cook, Medical, Medline Industries, Merit Medical, Systems, Inc., Olympus Corporation, Teleflex Incorporated are some of the key players in the market.

    In 2021, the market was led by the kidney stones category. The adoption of a sedentary lifestyle and dietary practises that cause urolithiasis are two factors that are fueling the expansion of this market segment.

    The market is primarily being driven by the rising prevalence of urological and kidney-related illnesses as well as the use of technologically sophisticated stents for safe and efficient urological treatments.

    The study period of the market is 2016-2028.